E-commerce Contacto
/contact

Hawes, Endosonografía 4 edición

Robert H. Hawes


  1. Sección VII: Ultrasonido intervencionista
  2. Cap. 25 Terapia de ablación e intervenciones del plexo celíaco guiadas por ultrasonido endoscópico
Regresar

Capítulo 25 Terapia de ablación e intervenciones del plexo celíaco guiadas por ultrasonido endoscópico.

  1. Pai M, Yang J, Zhang Xet al., et al. PWE-055 endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) for pancreatic ductal adenocarcinoma. Gut. 2013;62. A153.
  2. Pai M, Habib N, Senturk Het al., et al. Endoscopic ultrasound guided radiofrequency ablation for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg. 2015;7:52–59.
  3. Song TJ, Seo DW, Lakhtakia Set al., et al. Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc. 2016;83:440–443.
  4. Lakhtakia S, Ramchandani M, Galasso Det al., et al. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode. Gastrointest Endosc. 2016;83:234–239.
  5. Jin ZD, Wang L, Li Z. Endoscopic ultrasound-guided celiac ganglion radiofrequency ablation for pain control in pancreatic carcinoma. Dig Endosc. 2015;27:163–164.
  6. Carrara S, Arcidiacono PG, Albarello Let al., et al. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy. 2008;40:321–326.
  7. Arcidiacono PG, Carrara S, Reni Met al., et al. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc. 2012;76:1142–1151.
  8. Skandarajah AR, Lynch AC, Mackay JRet al., et al. The role of intraoperative radiotherapy in solid tumors. Ann Surg Oncol. 2009;16:735–744.
  9. Calvo FA, Meirino RM, Orecchia R. Intraoperative radiation therapy part 2. Clinical results. Crit Rev Oncol Hematol. 2006;59:116–127.
  10. Sun S, Xu H, Xin Jet al., et al. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy. 2006;38:399–403.
  11. Jin Z, Du Y, Li Zet al., et al. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy. 2008;40:314–320.
  12. Jin Z, Du Y, Li Z. Su1575 long-term effect of gemcitabine-combined endoscopic ultrasonography-guided brachytherapy in pancreatic cancer. Gastrointest Endosc. 2013;77. AB373.
  13. Jiang TA, Deng Z, Tian Get al., et al. Efficacy and safety of endoscopic ultrasonography-guided interventional treatment for refractory malignant left-side liver tumors: a case series of 26 patients. Sci Rep. 2016;6:36098.
  14. Pishvaian AC, Collins B, Gagnon Get al., et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc. 2006;64:412–417.
  15. Park WG, Yan BM, Schellenberg Det al., et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc. 2010;71:513–518.
  16. Fabbri C, Luigiano C, Lisotti Aet al., et al. Endoscopic ultrasound-guided treatments. Are we getting evidence based-a systematic review. World J Gastroenterol. 2014;20:8424–8448.
  17. Yang J, Abdel-Wahab M, Ribeiro A. EUS-guided fiducial placement after radical prostatectomy before targeted radiation therapy for prostate cancer recurrence. Gastrointest Endosc. 2011;73:1302–1305.
  18. Chandran S, Vaughan R, Efthymiou Met al., et al. A pilot study of EUS-guided fiducial insertion for the multidisciplinary management of gastric cancer. Endosc Int Open. 2014;2:153–159.
  19. Machiels M, van Hooft J, Jin Pet al., et al. Endosocpy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers. Gastrointest Endosc. 2015;82(4):641–649.
  20. Law JK, Singh VK, Khashab MAet al., et al. Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery. Surg Endosc. 2013;27:3921–3926.
  21. Okuzono T, Kanno Y, Nakahori Met al., et al. Preoperative endoscopic ultrasonography-guided tattooing of the pancreas with a minuscule amount of marking solution using a newly designed injector. Dig Endosc. 2016;28:744–748.
  22. Wang KX, Jin ZD, Du YQet al., et al. EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain control in pancreatic carcinoma: a prospective pilot study. Gastrointest Endosc. 2012;76:945–952.
  23. Jurgensen C, Schuppan D, Neser Fet al., et al. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc. 2006;63:1059–1062.
  24. Levy MJ, Thompson GB, Topazian MDet al., et al. EUS-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc. 2012;75:200–206.
  25. Qin SY, Lu XP, Jiang HX. EUS-guided ethanol ablation of insulinomas: case series and literature review. Medicine (Baltimore). 2014;93:1–5.
  26. Artifon EL, Cunha MAB, Da Silveira EBet al., et al. 349 EUS-guided or interventional radiology to hepatic intra-arterial chemotherapy: a prospective trial. Gastrointest Endosc. 2013;77:AB142–AB143.
  27. Levy MJ, Alberts SR, Bamlet WRet al., et al. EUS guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer. Gastrointest Endosc. 2017;86:161–169.
  28. Chang KJ, Nguyen PT, Thompson JAet al., et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer. 2000;88:1325–1335.
  29. Hecht JR, Bedford R, Abbruzzese JLet al., et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res. 2003;9:555–561.
  30. Irisawa A, Takagi T, Kanazawa Met al., et al. Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study. Pancreas. 2007;35:189–190.
  31. Hirooka Y, Itoh A, Kawashima Het al., et al. A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Pancreas. 2009;38:e69–e74.
  32. Hecht JR, Farrell JJ, Senzer Net al., et al. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012;75:332–338.
  33. Herman JM, Wild AT, Wang Het al., et al. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol. 2013;31:886–894.
  34. Chang KJ, Reid T, Senzer Net al., et al. Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer. Gastrointest Endosc. 2012;75:1139–1146.
  35. DiMaio CJ, DeWitt JM, Brugge WR. Ablation of pancreatic cystic lesions: the use of multiple endoscopic ultrasound-guided ethanol lavage sessions. Pancreas. 2011;40:664–668.
  36. Gan SI, Thompson CC, Lauwers GYet al., et al. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc. 2005;61:746–752.
  37. DeWitt J, McGreevy K, Schmidt CM, Brugge WR. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc. 2009;70:710–723.
  38. DeWitt J, DiMaio CJ, Brugge WR. Long-term follow-up of pancreatic cysts that resolve radiologically after EUS-guided ethanol ablation. Gastrointest Endosc. 2010;72:862–866.
  39. Oh HC, Seo DW, Song TJet al., et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology. 2011;140:172–179.
  40. DeWitt JM, Al-Haddad M, Sherman Set al., et al. Alterations in cyst fluid genetics following endoscopic ultrasound-guided pancreatic cyst ablation with ethanol and paclitaxel. Endoscopy. 2014;46:457–464.
  41. Oh HC, Seo DW, Kim SCet al., et al. Septated cystic tumors of the pancreas: is it possible to treat them by endoscopic ultrasonography-guided intervention? Scand J Gastroenterol. 2009;44:242–247.
  42. Moyer MT, Dye CE, Sharzehi Set al., et al. Is alcohol required for effective pancreatic cyst ablation? The prospective randomized CHARM trial pilot study. Endosc Int Open. 2016;4:603–607.
  43. Vranken JH, Zuurmond WW, Van Kemenade FJ, Dzoljic M. Neurohistopathologic findings after a neurolytic celiac plexus block with alcohol in patients with pancreatic cancer pain. Acta Anaesthesiol Scand. 2002;46:827–830.
  44. Puli SR, Reddy JB, Bechtold MLet al., et al. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci. 2009;54:2330–2337.
  45. Wyse JM, Carone M, Paquin SCet al., et al. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011;29:3541–3546.
  46. Sahai AV, Lemelin V, Lam E, Paquin SC. Central versus bilateral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness. Am J Gastroenterol. 2009;104:326–329.
  47. Tellez-Avila FI, Romano-Munive AF, Herrera-Esquivel Jde J, Ramirez-Luna MA. Central is as effective as bilateral endoscopic ultrasound-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer. Endoscopic Ultrasound. 2013;2:153–156.
  48. LeBlanc JK, DeWitt J, Johnson Cet al., et al. A prospective randomized trial of 1 versus 2 injections during EUS-guided celiac plexus block for chronic pancreatitis pain. Gastrointest Endosc. 2009;69:835–842.
  49. Sakamoto H, Kitano M, Kamata Ket al., et al. EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle. Am J Gastroenterol. 2010;105:2599–2606.
  50. Minaga K, Kitano M, Sakamoto Het al., et al. Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer. Therap Adv Gastroenterol. 2016;9:483–494.
  51. Levy MJ, Topazian MD, Wiersema MJet al., et al. Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct ganglia neurolysis and block. Am J Gastroenterol. 2008;103:98–103.
  52. Ascunce G, Ribeiro A, Reis Iet al., et al. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video). Gastrointest Endosc. 2011;73:267–274.
  53. Doi S, Yasuda I, Kawakami Het al., et al. Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial. Endoscopy. 2013;45:362–369.
  54. O’Toole TM, Schmulewitz N. Complication rates of EUS-guided celiac plexus blockade and neurolysis: results of a large case series. Endoscopy. 2009;41:593–597.
  55. Bang JY, Hasan MK, Sutton Bet al., et al. Intraprocedural increase in heart rate during EUS-guided celiac plexus neurolysis: clinically relevant or just a physiologic change? Gastrointest Endosc. 2016;84:773–779.
Regresar